Tissue microarray has a lot of advantages, compared to traditional methods. Tissue microarray allows for high-throughput data collection and analysis of a large number of specimens at the same time. This method enables the analysis of samples from a single batch on a single slide, ensuring that variables like temperature, incubation time, washing interval, and antigen retrieval remain consistent. The procedure requires a tiny amount of reagent and is highly effective and efficient in a short period. The global Tissue Microarray market is projected to rise at a considerable rate in the forthcoming period.
The tissue microarray market is expected to grow due to factors such as an increase in the number of cases of tumour patients, technological advancements, and the adoption of microarray techniques in genomic and proteomic fields due to its rapid assay, uniformity in results, and fewer sample requirements.
On the downside, the high cost of microarray techniques and the preference of users for alternative techniques such as PCR are anticipated to detain the market growth in the forecast period.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Product, Application, End-User, and Region |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Abcam plc, Asterand Bioscience, Auria Biopankki, Externautics, Novus Biologicals, LLC, OriGene Technologies Inc., Protein Biotechnologies Inc, PREMIER Biosoft, Pantomics Inc., and US Biomax Inc. |
Covid-19 Impact on Tissue Microarray Market
In addition, the current Tissue Microarray Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Tissue Microarray Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Tissue Microarray Market Segment Overview
According to Product, the Paraffin-Embedded Tissue Array segment is projected to dominate the market in the forecast period. Based on the Application, the immunohistochemistry and in situ hybridization segments are estimated to hold noteworthy market shares in the forecast period owing to the rise in the adoption of protein expression methodology for the diagnosis of disease. The technique of tissue microarray is highly accurate and needs a skilled person to handle and analyze the output data. Therefore, the market for the hospital is estimated to witness high growth in the forecast period.
Tissue Microarray Market, By Product
· Cell Line Array
· Frozen Tissue Array
· Paraffin Embedded Tissue Array
· Tissue Array Slides
· Others
Tissue Microarray Market, By Application
· Immunohistochemistry
· FISH
· mRNA
· In Situ Hybridization
· Nucleic Acid Extraction
· Others
Tissue Microarray Market, By End-User
· Hospitals
· Clinics
· Diagnostic Centers
· Others
Tissue Microarray Market Regional Overview
Region-Wise, North America holds a noteworthy market share and is expected to retain its dominance in the forecast period. This is mainly due to the rise in health care expenditure, advanced technology adoption, and an increase in the number of cases of cancer. Similarly, the market in the Asia Pacific is expected to rise at a considerable rate in the coming years. This is because of the rising healthcare expenditure and emerging healthcare infrastructure in this region.
Tissue Microarray Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Tissue Microarray Market, Key Players
· Abcam plc
· Asterand Bioscience
· Auria Biopankki
· Externautics
· Novus Biologicals, LLC
· OriGene Technologies Inc.
· Protein Biotechnologies Inc
· PREMIER Biosoft
· Pantomics Inc.
· US Biomax Inc.
Frequently Asked Questions (FAQ) :
Q1. What are the restraining factors for the Tissue Microarray market?
Q2. Which Segments are covered in the Tissue Microarray Market report?
Q3. Which segment is projected to hold the largest share in the Tissue Microarray Market?
Q4. Which region holds the largest share in the Tissue Microarray market?
Q5. Which are the prominent players in the Tissue Microarray Market?
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Tissue Microarray Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Cell Line Array
- 5.2.2. Frozen Tissue Array
- 5.2.3. Paraffin Embedded Tissue Array
- 5.2.4. Tissue Array Slides
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Immunohistochemistry
- 5.3.2. FISH
- 5.3.3. mRNA
- 5.3.4. In Situ Hybridization
- 5.3.5. Nucleic Acid Extraction
- 5.3.6. Others
- 5.4. Market Analysis, Insights and Forecast – By End-User
- 5.4.1. Hospitals
- 5.4.2. Clinics
- 5.4.3. Diagnostic Centers
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Tissue Microarray Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Cell Line Array
- 6.2.2. Frozen Tissue Array
- 6.2.3. Paraffin Embedded Tissue Array
- 6.2.4. Tissue Array Slides
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Immunohistochemistry
- 6.3.2. FISH
- 6.3.3. mRNA
- 6.3.4. In Situ Hybridization
- 6.3.5. Nucleic Acid Extraction
- 6.3.6. Others
- 6.4. Market Analysis, Insights and Forecast – By End-User
- 6.4.1. Hospitals
- 6.4.2. Clinics
- 6.4.3. Diagnostic Centers
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Tissue Microarray Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Cell Line Array
- 7.2.2. Frozen Tissue Array
- 7.2.3. Paraffin Embedded Tissue Array
- 7.2.4. Tissue Array Slides
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Immunohistochemistry
- 7.3.2. FISH
- 7.3.3. mRNA
- 7.3.4. In Situ Hybridization
- 7.3.5. Nucleic Acid Extraction
- 7.3.6. Others
- 7.4. Market Analysis, Insights and Forecast – By End-User
- 7.4.1. Hospitals
- 7.4.2. Clinics
- 7.4.3. Diagnostic Centers
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Tissue Microarray Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Cell Line Array
- 8.2.2. Frozen Tissue Array
- 8.2.3. Paraffin Embedded Tissue Array
- 8.2.4. Tissue Array Slides
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Immunohistochemistry
- 8.3.2. FISH
- 8.3.3. mRNA
- 8.3.4. In Situ Hybridization
- 8.3.5. Nucleic Acid Extraction
- 8.3.6. Others
- 8.4. Market Analysis, Insights and Forecast – By End-User
- 8.4.1. Hospitals
- 8.4.2. Clinics
- 8.4.3. Diagnostic Centers
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Tissue Microarray Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Cell Line Array
- 9.2.2. Frozen Tissue Array
- 9.2.3. Paraffin Embedded Tissue Array
- 9.2.4. Tissue Array Slides
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Immunohistochemistry
- 9.3.2. FISH
- 9.3.3. mRNA
- 9.3.4. In Situ Hybridization
- 9.3.5. Nucleic Acid Extraction
- 9.3.6. Others
- 9.4. Market Analysis, Insights and Forecast – By End-User
- 9.4.1. Hospitals
- 9.4.2. Clinics
- 9.4.3. Diagnostic Centers
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Abcam plc
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Asterand Bioscience
- 10.6. Auria Biopankki
- 10.7. Externautics
- 10.8. Novus Biologicals, LLC
- 10.9. OriGene Technologies Inc.
- 10.10. Protein Biotechnologies Inc
- 10.11. PREMIER Biosoft
- 10.12. Pantomics Inc.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
